Those of us in the field of education know the billionaire Sackler family as major funders of charter schools. Jonathan Sackler funded ConnCAN, then 50CAN, and sits on the boards of other charter promotion corporations.
But in the wider world, the Sacklers are infamous for their ownership of Purdue Pharmaceuticals, which manufactures and markets OxyContin, the drug believed to be responsible for the opioid addiction crisis and more than 200,000 deaths.
If Trump wanted to stop the flow of deadly drugs, he would build a wall around every Purdue factory, not the southern border.
ProPublica obtained and released a trove of documents that demonstrates that family members knew that their drug was twice as powerful as morphine, yet understated the risks.
“In May 1997, the year after Purdue Pharma launched OxyContin, its head of sales and marketing sought input on a key decision from Dr. Richard Sackler, a member of the billionaire family that founded and controls the company. Michael Friedman told Sackler that he didn’t want to correct the false impression among doctors that OxyContin was weaker than morphine, because the myth was boosting prescriptions — and sales.
“It would be extremely dangerous at this early stage in the life of the product,” Friedman wrote to Sackler, “to make physicians think the drug is stronger or equal to morphine….We are well aware of the view held by many physicians that oxycodone [the active ingredient in OxyContin] is weaker than morphine. I do not plan to do anything about that.”
“I agree with you,” Sackler responded. “Is there a general agreement, or are there some holdouts?”
“Ten years later, Purdue pleaded guilty in federal court to understating the risk of addiction to OxyContin, including failing to alert doctors that it was a stronger painkiller than morphine, and agreed to pay $600 million in fines and penalties. But Sackler’s support of the decision to conceal OxyContin’s strength from doctors — in email exchanges both with Friedman and another company executive — was not made public.
“The email threads were divulged in a sealed court document that ProPublica has obtained: an Aug. 28, 2015, deposition of Richard Sackler. Taken as part of a lawsuit by the state of Kentucky against Purdue, the deposition is believed to be the only time a member of the Sackler family has been questioned under oath about the illegal marketing of OxyContin and what family members knew about it. Purdue has fought a three-year legal battle to keep the deposition and hundreds of other documents secret, in a case brought by STAT, a Boston-based health and medicine news organization; the matter is currently before the Kentucky Supreme Court….
”Much of the questioning of Sackler in the 337-page deposition focused on Purdue’s marketing of OxyContin, especially in the first five years after the drug’s 1996 launch. Aggressive marketing of OxyContin is blamed by some analysts for fostering a national crisis that has resulted in 200,000 overdose deaths related to prescription opioids since 1999.
“Taken together with a Massachusetts complaint made public last month against Purdue and eight Sacklers, including Richard, the deposition underscores the family’s pivotal role in developing the business strategy for OxyContin and directing the hiring of an expanded sales force to implement a plan to sell the drug at ever-higher doses. Documents show that Richard Sackler was especially involved in the company’s efforts to market the drug, and that he pushed staff to pursue OxyContin’s deregulation in Germany. The son of a Purdue co-founder, he began working at Purdue in 1971 and has been at various times the company’s president and co-chairman of its board…
”The Kentucky deposition’s contents will likely fuel the growing protests against the Sacklers, including pressure to strip the family’s name from cultural and educational institutions to which it has donated. The family has been active in philanthropy for decades, giving away hundreds of millions of dollars. But the source of its wealth received little attention until recent years, in part due to a lack of public information about what the family knew about Purdue’s improper marketing of OxyContin and false claims about the drug’s addictive nature.”
The Sackler family has a net worth of some $14 billion.
Madeline Sackler, film-maker, produced a documentary lauding Eva Moskowitz’s Success Academy called “The Lottery.”

Same old formula. People with no real value of their own find ways to insert themselves in the pipeline between people who have a need and people who serve that need and then they feed off their power to squat on the valve. And if there is not enough natural need for them to profit off it then they look for ways to create artificial needs in people. And they feed and feed and feed off people’s needs.
LikeLike
Yes…they feed off of people’s needs, but what is worse is that they manufacture a want into a need. Marketing is such a sleazy business. It’s a bunch of smoke and mirrors.
LikeLike
Posted this at OPED News: https://www.opednews.com/Quicklink/Will-the-Sackler-Family-Be-in-Best_Web_OpEds-Doctors_Drugs_Opioids-Narcotics_Oxycontin-190225-358.html#comment726233
LikeLike
Then, there is this, how big Pharma hurts us all…. It is “time for big Pharma to have its day in court!” https://www.nytimes.com/2019/02/24/opinion/drug-prices-congress.html?action=click&module=Opinion&pgtype=Homepage
“Twenty-five years ago, Congress hauled before itthe top executives of the nation’s seven largest tobacco companies and forced them to make a number of long-overdue admissions about cigarettes including that they might cause cancer and heart disease and that the executives had suppressed evidence of their addictive potential.”
“The hearing ushered in a public health victory for the ages. In its wake, lawmakers and health officials enacted measures that would ultimately bring smoking rates in the United States to an all-time low.”
“With seven pharmaceutical executives set to testify before theSenate Finance Committee on Tuesday, one can only hope for a similarly pivotal moment for prescription drug prices. Like their predecessors in the tobacco industry, the drug makers will testify at a time of near-universal anger over industry antics.”
LikeLike
How many billionaires that are guilty due to the evidence ever end up in prison?
If their high prices lawyers don’t get them off by attacking the authorities to make them look like they are guilty so the jury will doubt the evidence no matter how powerful it is, the usual punishment for the super wealthy is a fine (that is a lot less than what they made from their crime) and sometimes they are barred from ever working in that specific industry where they committed their crimes.
Few of the super wealthy ever end up in a real prison and the few that do spend their time in what’s labeled a prision end up playing tennis in one of the ountry club prisons that were built for wealthy white-collar criminals.
Didn’t Guiliani, Trump current demented lawyer (I’m amazed Trump hasn’t fired him yet), say that white-collar crimes were not crimes?
LikeLike
You’re right, Lloyd. Justice is far from blind. Sadly, we have a tiered justice system for most offenses with rules that differ on who you are, who you can afford as defense and the size of your wallet.
LikeLike
The only difference between the Blood-Sucklers and El Chapo is the former bought the right politicians …
LikeLike
To me this atrocity rises above and beyond the daily insults of corporate-corrupted govt. We knew of the Oxycontin marketing scandal. It is quite another thing to read the words of its doers– planning, exhorting, exulting– naked greed devoid of concern for humanity. I am stunned by the email. And the background about the failed attempt in Germany. The in-house communications reveal a mentality and corporate culture no different from a shady club where heroin bosses plot the street-corner profits to be made by spreading deadly disease.
This is not parallel to tobacco. Regardless of unscrupulous industry schemes to market ever-more addictive products, attract youngsters etc, tobacco remains a personal indulgence clearly marked [since 1965!] w/its dangers. It is not a medical treatment.
The marketing of Oxycontin targeted the healthcare industry at a vulnerable moment, early in the devpt of pain mgt as a medical specialty. A small series of trials was showing that longer-term opioids were not necessarily addictive (but there was no longterm data). Consensus was forming around limited opioids supplemented by newer [non-addictive] drugs, in combination w/various non-drug therapies– but insurance industry was not behind this expensive multi-disc approach.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940677/
So the table was set for a bad actor.
No brakes could have been expected from the underfunded, deregulated FDA at that point– & the DEA could be counted on to blunder in at random to upset the med applecart. The AMA/ docs have a piece in this too. But mistakes made there get back around to our healthcare delivery system. It would be better if opioids were prescribed by specialists, but that lends itself more to a multi-disc team setting [like a hospital]; our docs are mostly siloed in single-disc practices.
LikeLike
National Portrait Gallery in London has turned down £1m grant from Sackler family:
https://www.theguardian.com/artanddesign/2019/mar/19/national-portrait-gallery-turns-down-grant-from-sackler-family-oxycontin
LikeLike
That is very good news indeed. If only other institutions had the courage to say no to blood money.
LikeLike